Lifestyle Changes in PCOS with OSA and NAFLD

Cairo University (CU)

Status: Enrolling

Conditions: PCOS; NAFLD; OSA

Treatments: Behavioral: diet restriction and exercise; Behavioral: diet restriction

Study type: Interventional

Funder types: Other

Identifiers

NCT06591169

P.T.REC/012/005321

Details and patient eligibility

About

Complain of obstructive sleeping apnea and fatty liver is common in PCOS women so lifestyle changes are recommended

Full description

Forty obese PCOS men with obstructive sleeping apnea and compaint of fatty liver will participate in this trial . Group (study group) will contain twenty obese females with a complaint of PCOS and OSA and fatty liver. for eight weeks, these obese females will receive metformin tablet (thrice daily), program of low diet intake, and daily walking for 30 minutes. Group (control group) will contain twenty obese females with a complaint of PCOS and OSA and fatty liver . for eight weeks, these obese females will receive metformin tablet (thrice daily), program of low diet intake,

Enrollment: 40 estimated patients

Sex: Female

Ages: 30 to 40 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• forty women
• women complaint PCOS
• women complain obstructive sleep apnea
• women are obese
• women complain fatty liver

Exclusion criteria

• cardiac insult
• renal insult
• malignacy
• pregnancy

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

40 participants in 2 patient groups

study

Experimental group

Description:

this group will contain twenty obese females with a complaint of NAFLD, PCOS and OSA. for eight weeks, these obese females will receive metformin tablet (thrice daily), program of low diet intake, and daily walking for 30 minutes

Treatment:

Behavioral: diet restriction and exercise

control group

Active Comparator group

Description:

this group will contain twenty obese females with a complaint of NAFLD, PCOS and OSA. for eight weeks, these obese females will receive metformin tablet (thrice daily) and program of low diet intake

Treatment:

Behavioral: diet restriction